$SGYP’s valuation closed ~ $0 as $BHC won court approval to buy the firm for $195M. $SGYPQ, SYNERGY PHARMACEUTICALS INC DEL / H1 Mylan $MYL tanked after that weak earnings report. With all that cash flow, why does Mylan not buy back stock and issue a dividend? MYL -15%. Are you buying the dip? $MYL, Mylan N.V. / H1 $NIO slipped below $10. Short. Buy Puts. The insider lockup expires soon. $AAPL, Apple Inc. / H1 Trade deal worries once again are the headline news markets will use to sell down Micron $MU and $AMD. AMD continues to take a bit of market share but $INTC Intel is still the true king. Intel hardly relies on the PC/notebook market. It holds Altera and Mobileye for growth. $SNAP sub-$10. What is it doing above $5? $SNAP, Snap Inc. / H1 $CVS, $UNH are under fire. These are solid pharmacies. Buy. $CVS, CVS Health Corporation / H1 In the resource space, $CHK posted strong results. $3 next. $FCX is a favorite, too. $NVDA Nvidia is dipping. Beware. $NVDA, NVIDIA Corporation / H1 Post your trades and share your ideas with ~900 members.